The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

AUGUST 19, 2021

Cannabidiol or CBD, which is most commonly sold as oil at high street retailers, is one of the active ingredients of non-psychoactive cannabis. Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. What can the current clinical trials tell us? As long as the product contains <0.3%

THC 140

THC Sleep Clinical Trials Cannabinoids 140

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. ” Using CBD Oil To Treat Seizures.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

CannaMD

AUGUST 8, 2020

When people say they’re buying or using “CBD,” they’re referring to products (most often oils) that are rich in this compound. Unlike marijuana-derived CBD products, which can contain a high percentage of THC, hemp-derived CBD oil, also called hemp oil , never has more than 0.3% CBD & Epidiolex.

CBD 100

CBD DEA Research and Development Hemp 100

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 25, 2021

Epilepsy Treatment. This study is, of course, well-vetted, and has offered plenty of hope to sufferers of epilepsy. The use of CBD seems to ease the number of seizures patients have considerably, which has caused many medical professionals to take notice and begin prescribing it to others. Ease Opioid Addiction.

CBD 52

CBD Clinical Trials Epilepsy Chronic Pain 52

Cannabis Law Report

FEBRUARY 3, 2022

Patients suffering from chronic diseases, like Parkinson’s, Alzheimer’s, cancer, and many neurological disorders, are administered cannabis. The demand for cannabis oil is growing due to its wellness and health purpose. Oils are also used in production of creams and balms that can be absorbed through skin.

Indica 52

Indica Oil Legalization Research and Development 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

Ultimately, cannabis for mental health seems to boil down to questions of individual patient suitability. CBD is consumable in many different forms, from simple oils to more robust tinctures, infused edible products, or inhaling smoke from dried cannabis flower through smoking or a vaporizer.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

The Cannigma

JUNE 15, 2021

Cannabis products such as oils, tinctures and creams are usually decarboxylated as part of their preparation. Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. Jayden found freedom from his seizures with high-CBD cannabis oil. . Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

The Joint Blog

FEBRUARY 24, 2021

This is not the first medicinal trial of its kind. Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? The effects were so promising that Parkinson’s UK began funding for the worlds first clinical trial.

Treatment 55

Treatment Clinical Trials Collective Patients 55

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

capsule, oil, topical, edible). Currently, CBN can be purchased in the form of oils, capsules, tea bags, tinctures, patches, and disposable vape pens. Here are some of the most common effects CBN may have on patients: Wound Healing and Anti-Inflammatory Properties. It can also be purchased as a CBN isolate.

Sleep 94

Sleep Cannabinoids THC CBD 94

Cannabis Law Report

JULY 15, 2019

Law 33/2018 set the framework for the regulation of the use of cannabis-based medicinal products, preparations and substances that would effectively allow Portuguese patients to access medical cannabis What really has changed during the last year? dried flower and oils) are now clearly considered as a separate and distinct class od products.

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

JANUARY 24, 2022

where marijuana for recreational use has been legalized, the market has witnessed a dynamic shift of patients from traditional methods or medicine to opting to use marijuana for medical and other purposes. North America Legal Cannabis Number of clinical trials. Oils and Tinctures. In countries, such as Canada and the U.S.,

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Project CBD

FEBRUARY 28, 2023

1 SPINS’ CBD category typically includes sales of products that contain hemp-based CBD extracts, including CBD oils, gummies, and capsules. Products in SPINS’ hemp seeds and derivatives category, such as hemp seed oil (also written as “hempseed” oil), often are marketed for their nutritional content. 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

DECEMBER 23, 2021

In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals. The author has identified at least 30 late-stage clinical trials using cannabinoid therapeutics, any of which could have a large impact on the medicinal cannabis space.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Peninsula Alternative Health

MAY 15, 2019

For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

MGC Pharma

FEBRUARY 20, 2018

CBD passes Stage 3 clinical trial for the treatment of epilepsy in children A study published last year in The New England Journal of Medicine saw scientists studying the effects of CBD on epileptic seizures in patients with Dravet syndrome, a severe epileptic disorder leading to frequent and uncontrollable seizures in children.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Otherside Farms

APRIL 14, 2020

In another study, people dealing with epilepsy were given 200-300mg of CBD daily and began to experience fewer seizures. approved the use of a CBD-based drug called Epidiolex to treat seizures in patients aged 2 years and above. The early clinic trial of cannabis saw it being used to treat symptoms such as nausea and vomiting.

CBD 52

CBD Research and Development Sleep Clinical Trials 52

Peninsula Alternative Health

MAY 15, 2019

For now, we can use a variety of strains in the form of concentrated cannabis oil to hopefully get lucky and find the right one. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Oil and Tinctures. Switzerland.

Recreational 95

Recreational Hemp THC Legalization 95

SMPL

MAY 26, 2020

Miller spent the months after this meeting leading hundreds of CBD seminars for farmers; Dr. Kerr began informal patient surveys to track how CBD made people feel; and as he finished his book, Mr. Lee often traveled around with Mr. Laughter and Mr. Ringo’s high-CBD plants and seeds, spreading the gospel at pot shops across the West.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

JULY 15, 2022

“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.

Medicine 52

Medicine Patients Media Supply Chain 52

The Cannigma

DECEMBER 22, 2021

It’s either dried flower, pre-rolls, or oil. Anything other than that needs to go through a clinical process, and that has not been done yet. Obviously, that means that there are more patients and there are more products to sell. We have autism and epilepsy. EG: Okay, these oils, I presume. That’s it.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Green Relief

MAY 12, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Puff Puff Post

DECEMBER 28, 2018

One recent observational study has shown an astonishing success rate of 80% in reducing negative behavioral patterns in test subjects by using CBD oil. We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism. CBD Oil For Autism: Highlights.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

MARCH 21, 2019

In order to legally posses CBD in Alabama , you must be in accordance to Leni’s Law which states you must be diagnosed with a debilitating medical condition and be undergoing treatment or you are part of a state-sponsored clinical trial. In 2014, Mississippi legalized CBD for epileptic patients.

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

OCTOBER 17, 2019

Hemp’s fibers, seeds, and flowers can be used to make paper, textiles, construction materials, rope, hemp seeds and hemp seed oils, and much more. The new law rolled out first with dried cannabis and low-concentration cannabis oils. Hemp has been used for these purposes for centuries in cultures around the world. The sky’s the limit.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

DECEMBER 30, 2019

Since 2014, annual appropriations bills have been amended to include a spending restriction to prevent the Department of Justice from enforcing the federal prohibition of marijuana against state-legal medical cannabis programs, businesses, and patients. Included in the final FY 2020 spending package). It took immediate effect upon passage.

Legislation 59

Legislation Patients Access Banking 59